一种现成的人造血块凝块水凝,中和多种抗炎媒介,用于治疗再生性牙周炎
Yini Huangfu1, Zhezhe Zhao2, Xiang Liu1
1Department of Polymer Science and Engineering, Key Laboratory of Systems Bioengineering (Ministry of Education), School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, P. R. China.
概括
这项研究引入了含有富血小板血 (PRP) 的人工血栓水凝,以对抗牙周炎炎症. 水凝有效降低炎症媒介,并促进牙周组织的修复.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 免疫学 免疫学 免疫学
背景情况:
- 牙周炎是一种慢性炎症性疾病,其特点是具有破坏性的炎症媒介.
- 目前的治疗方法侧重于细菌的消除,但对牙周炎症的管理仍然对再生具有挑战性.
- 解决炎症微环境对于有效的牙周炎治疗至关重要.
研究的目的:
- 开发一种用富血小板血 (PRP) 封装的人工血栓水凝,以减轻牙周炎引起的炎症.
- 研究工程水凝的免疫调节和再生能力.
- 评估水凝在老鼠牙周炎模型中的治疗潜力.
主要方法:
- 制造一个层次纤维交织的水凝 (CCS-RSF@PRP),模仿本地血块.
- 在水凝结构中封装富血小板血 (PRP).
- 在实验室中对ROS清除,内毒素中和细胞因子调节的评估.
- 在老鼠牙周炎模型中的体内评估,以评估牙周修复和免疫环境正常化.
主要成果:
- 该CCS-RSF@PRP水凝有效地清除活性氧物种 (ROS) 并中和脂多糖 (LPS) 和促炎细胞因子 (TNF-α,IFN-γ,IL-1β).
- 水凝抑制M1巨细胞的两极化,促进M2两极化,从而阻断慢性炎症的反循环.
- 在大鼠模型中,CCS-RSF@PRP水凝通过使牙周免疫环境正常化,显著加速了牙周修复.
结论:
- 工程制造的PRP衍生水凝有效地减轻了牙周炎的炎症环境.
- 水凝模仿并增强天然血栓的功能,提供了一个有前途的治疗策略.
- 通过工程水凝进行局部免疫调节,对于治疗牙周炎等慢性炎症性疾病具有重大潜力.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
260
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
260
Formation of the Platelet Plug
7.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.2K
Clot Retraction and Fibrinolysis
6.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.9K


